<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2016-07-11 16:59:42Rheumatology Inborn errors of purine-pyrimidine metabolism Uric acid Pegloticase Savient pharmaceuticals Hyperuricemia Urate oxidase Tophus Gout PEGylation ULT Allantoin |
Add to Reading List |
Microsoft Word - Savient Receives Positive Opinion for KRYSTEXXA Approval in EU | Microsoft Word - Savient Press Release ACRdocDocID: 1rrcY - View Document |
 | Microsoft Word - Savient press release re ACRdocDocID: 1reUR - View Document |
 | Microsoft Word - Savient press release on ACRdocDocID: 1pWM3 - View Document |
 | Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 StudiesDocID: 1pRtE - View Document |
 | Microsoft Word - Savient press release re OLEdocDocID: 1pDKY - View Document |